Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | https://doi.org/10.1590/1678-4162-12125 http://hdl.handle.net/1843/56458 http://orcid.org/0000-0002-9676-7745 http://orcid.org/0000-0002-0233-7729 http://orcid.org/0000-0001-8741-1213 http://orcid.org/0000-0002-7852-6809 http://orcid.org/0000-0001-5922-3450 http://orcid.org/0000-0002-8754-8524 http://orcid.org/0000-0003-2016-2210 http://orcid.org/0000-0001-8068-5211 http://orcid.org/0000-0001-9980-3169 http://orcid.org/0000-0001-7714-991X http://orcid.org/0000-0002-1715-3834 http://orcid.org/0000-0002-1835-0303 http://orcid.org/0000-0002-5650-6743 |
Resumo: | The present work evaluated the immunomodulatory effect of thalidomide (Thal) at different doses on tumor-associated macrophages (TAMs) using a mouse model of human breast cancer. Mice were inoculated with 4T1 cells in the left flank and treated with Thal once a day at concentrations of 50, 100, and 150mg/kg body weight from the 5th day until the 28th day of tumor inoculation. The tumors were sized, proliferation index and TAMs count were evaluated in primary tumors and metastatic lungs. In addition, the metastasis rate was evaluated in the lungs. Thal at 150mg/kg significantly decreased tumor growth, proliferation index, and TAMs infiltration in primary tumors. Conversely, a higher number of TAMs and lower proliferation index were observed in metastatic lungs in mice treated with 150mg/kg of Thal. Furthermore, Thal at 150mg/kg significantly decreased the metastatic nodules in the lungs. Our findings demonstrated that Thal treatment considerably decreased the primary tumor and lung metastasis in mice associated with different TAM infiltration effects in these sites. |
id |
UFMG_35bd44228926a691cf004cc0c58ddd89 |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/56458 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
2023-07-17T19:09:41Z2023-07-17T19:09:41Z202173613341345https://doi.org/10.1590/1678-4162-121251678-4162http://hdl.handle.net/1843/56458http://orcid.org/0000-0002-9676-7745http://orcid.org/0000-0002-0233-7729http://orcid.org/0000-0001-8741-1213http://orcid.org/0000-0002-7852-6809http://orcid.org/0000-0001-5922-3450http://orcid.org/0000-0002-8754-8524http://orcid.org/0000-0003-2016-2210http://orcid.org/0000-0001-8068-5211http://orcid.org/0000-0001-9980-3169http://orcid.org/0000-0001-7714-991Xhttp://orcid.org/0000-0002-1715-3834http://orcid.org/0000-0002-1835-0303http://orcid.org/0000-0002-5650-6743The present work evaluated the immunomodulatory effect of thalidomide (Thal) at different doses on tumor-associated macrophages (TAMs) using a mouse model of human breast cancer. Mice were inoculated with 4T1 cells in the left flank and treated with Thal once a day at concentrations of 50, 100, and 150mg/kg body weight from the 5th day until the 28th day of tumor inoculation. The tumors were sized, proliferation index and TAMs count were evaluated in primary tumors and metastatic lungs. In addition, the metastasis rate was evaluated in the lungs. Thal at 150mg/kg significantly decreased tumor growth, proliferation index, and TAMs infiltration in primary tumors. Conversely, a higher number of TAMs and lower proliferation index were observed in metastatic lungs in mice treated with 150mg/kg of Thal. Furthermore, Thal at 150mg/kg significantly decreased the metastatic nodules in the lungs. Our findings demonstrated that Thal treatment considerably decreased the primary tumor and lung metastasis in mice associated with different TAM infiltration effects in these sites.No presente trabalho, foi avaliado o efeito imunomodulador de diferentes doses de talidomida em macrófagos associados ao tumor (TAMs), em um modelo murino de câncer de mama. Camundongos foram inoculados com células 4T1, na região do flanco esquerdo, e tratados com talidomida, uma vez ao dia, nas doses de 50, 100 e 150mg/k, por massa corporal, do quinto dia ao 28º dia de inoculação tumoral. Os tumores foram medidos, o índice de proliferação celular e a contagem de TAMs foram avaliados nos tumores primários e nos pulmões com metástases. Além disso, a taxa de metástases pulmonares também foi avaliada. A talidomida na dose de 150mg/kg diminuiu significativamente o crescimento tumoral, o índice de proliferação celular e a infiltração de TAMs nos tumores primários. Por outro lado, maior número de TAMs e menor índice de proliferação celular foram observados nos pulmões metastáticos, em camundongos tratados com 150mg/kg de talidomida. Ademais, a talidomida na dose de 150mg/kg diminuiu significativamente os nódulos metastáticos nos pulmões. Os resultados demonstraram que o tratamento com talidomida diminuiu o crescimento tumoral e as metástases pulmonares em camundongos, associado com diferentes efeitos na infiltração de TAMs nesses locais.CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorengUniversidade Federal de Minas GeraisUFMGBrasilICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIAICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICAICB - DEPARTAMENTO DE PATOLOGIAArquivo Brasileiro de Medicina Veterinária e ZootecniaNeoplasias da mamaImunomodulaçãoTalidomidaInflamaçãoMacrófagos associados a tumorBreast cancerImmunomodulationThalidomideInflammationTumor-associated macrophagesEvaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer modelAvaliação do efeito imunomodulador da talidomida em macrófagos associados a tumores no modelo murino de câncer de mama metastático 4T1info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://www.scielo.br/j/abmvz/a/h3zknQTLNrj7Y9FcBYNvjCg/?lang=en#Diego Carlos Dos ReisMichele Angela RodriguesSophia Gia Brandão PintoAna Cândida Araújo e SilvaGiovana Vieira MoreiraLiliane Cunha CamposPaula Peixoto CamposSílvia Ligório FialhoMiriam Teresa Paz LopesDawidson Assis GomesRemo de Castro RussoEnio FerreiraGeovanni Dantas Cassaliapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/56458/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALEvaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model.pdfEvaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model.pdfapplication/pdf1143949https://repositorio.ufmg.br/bitstream/1843/56458/2/Evaluation%20of%20the%20immunomodulatory%20activity%20of%20thalidomide%20on%20tumor-associated%20macrophages%20in%20the%204T1%20murine%20metastatic%20breast%20cancer%20model.pdfae2960afd363b50b1d78cdf82563ced5MD521843/564582023-07-17 16:09:41.995oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-07-17T19:09:41Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.pt_BR.fl_str_mv |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
dc.title.alternative.pt_BR.fl_str_mv |
Avaliação do efeito imunomodulador da talidomida em macrófagos associados a tumores no modelo murino de câncer de mama metastático 4T1 |
title |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
spellingShingle |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model Diego Carlos Dos Reis Breast cancer Immunomodulation Thalidomide Inflammation Tumor-associated macrophages Neoplasias da mama Imunomodulação Talidomida Inflamação Macrófagos associados a tumor |
title_short |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
title_full |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
title_fullStr |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
title_full_unstemmed |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
title_sort |
Evaluation of the immunomodulatory activity of thalidomide on tumor-associated macrophages in the 4T1 murine metastatic breast cancer model |
author |
Diego Carlos Dos Reis |
author_facet |
Diego Carlos Dos Reis Michele Angela Rodrigues Sophia Gia Brandão Pinto Ana Cândida Araújo e Silva Giovana Vieira Moreira Liliane Cunha Campos Paula Peixoto Campos Sílvia Ligório Fialho Miriam Teresa Paz Lopes Dawidson Assis Gomes Remo de Castro Russo Enio Ferreira Geovanni Dantas Cassali |
author_role |
author |
author2 |
Michele Angela Rodrigues Sophia Gia Brandão Pinto Ana Cândida Araújo e Silva Giovana Vieira Moreira Liliane Cunha Campos Paula Peixoto Campos Sílvia Ligório Fialho Miriam Teresa Paz Lopes Dawidson Assis Gomes Remo de Castro Russo Enio Ferreira Geovanni Dantas Cassali |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Diego Carlos Dos Reis Michele Angela Rodrigues Sophia Gia Brandão Pinto Ana Cândida Araújo e Silva Giovana Vieira Moreira Liliane Cunha Campos Paula Peixoto Campos Sílvia Ligório Fialho Miriam Teresa Paz Lopes Dawidson Assis Gomes Remo de Castro Russo Enio Ferreira Geovanni Dantas Cassali |
dc.subject.por.fl_str_mv |
Breast cancer Immunomodulation Thalidomide Inflammation Tumor-associated macrophages |
topic |
Breast cancer Immunomodulation Thalidomide Inflammation Tumor-associated macrophages Neoplasias da mama Imunomodulação Talidomida Inflamação Macrófagos associados a tumor |
dc.subject.other.pt_BR.fl_str_mv |
Neoplasias da mama Imunomodulação Talidomida Inflamação Macrófagos associados a tumor |
description |
The present work evaluated the immunomodulatory effect of thalidomide (Thal) at different doses on tumor-associated macrophages (TAMs) using a mouse model of human breast cancer. Mice were inoculated with 4T1 cells in the left flank and treated with Thal once a day at concentrations of 50, 100, and 150mg/kg body weight from the 5th day until the 28th day of tumor inoculation. The tumors were sized, proliferation index and TAMs count were evaluated in primary tumors and metastatic lungs. In addition, the metastasis rate was evaluated in the lungs. Thal at 150mg/kg significantly decreased tumor growth, proliferation index, and TAMs infiltration in primary tumors. Conversely, a higher number of TAMs and lower proliferation index were observed in metastatic lungs in mice treated with 150mg/kg of Thal. Furthermore, Thal at 150mg/kg significantly decreased the metastatic nodules in the lungs. Our findings demonstrated that Thal treatment considerably decreased the primary tumor and lung metastasis in mice associated with different TAM infiltration effects in these sites. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021 |
dc.date.accessioned.fl_str_mv |
2023-07-17T19:09:41Z |
dc.date.available.fl_str_mv |
2023-07-17T19:09:41Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1843/56458 |
dc.identifier.doi.pt_BR.fl_str_mv |
https://doi.org/10.1590/1678-4162-12125 |
dc.identifier.issn.pt_BR.fl_str_mv |
1678-4162 |
dc.identifier.orcid.pt_BR.fl_str_mv |
http://orcid.org/0000-0002-9676-7745 http://orcid.org/0000-0002-0233-7729 http://orcid.org/0000-0001-8741-1213 http://orcid.org/0000-0002-7852-6809 http://orcid.org/0000-0001-5922-3450 http://orcid.org/0000-0002-8754-8524 http://orcid.org/0000-0003-2016-2210 http://orcid.org/0000-0001-8068-5211 http://orcid.org/0000-0001-9980-3169 http://orcid.org/0000-0001-7714-991X http://orcid.org/0000-0002-1715-3834 http://orcid.org/0000-0002-1835-0303 http://orcid.org/0000-0002-5650-6743 |
url |
https://doi.org/10.1590/1678-4162-12125 http://hdl.handle.net/1843/56458 http://orcid.org/0000-0002-9676-7745 http://orcid.org/0000-0002-0233-7729 http://orcid.org/0000-0001-8741-1213 http://orcid.org/0000-0002-7852-6809 http://orcid.org/0000-0001-5922-3450 http://orcid.org/0000-0002-8754-8524 http://orcid.org/0000-0003-2016-2210 http://orcid.org/0000-0001-8068-5211 http://orcid.org/0000-0001-9980-3169 http://orcid.org/0000-0001-7714-991X http://orcid.org/0000-0002-1715-3834 http://orcid.org/0000-0002-1835-0303 http://orcid.org/0000-0002-5650-6743 |
identifier_str_mv |
1678-4162 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Arquivo Brasileiro de Medicina Veterinária e Zootecnia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.publisher.initials.fl_str_mv |
UFMG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA ICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICA ICB - DEPARTAMENTO DE PATOLOGIA |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
bitstream.url.fl_str_mv |
https://repositorio.ufmg.br/bitstream/1843/56458/1/License.txt https://repositorio.ufmg.br/bitstream/1843/56458/2/Evaluation%20of%20the%20immunomodulatory%20activity%20of%20thalidomide%20on%20tumor-associated%20macrophages%20in%20the%204T1%20murine%20metastatic%20breast%20cancer%20model.pdf |
bitstream.checksum.fl_str_mv |
fa505098d172de0bc8864fc1287ffe22 ae2960afd363b50b1d78cdf82563ced5 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
|
_version_ |
1803589547996479488 |